Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

AIMS: Vedolizumab (VDZ) prevents migration of activated leucocytes into inflamed mucosa. This study aimed to assess the patterns of serum cytokines in ulcerative colitis (UC) patients at baseline and during VDZ treatment, and to investigate their association with mucosal healing and clinical remissi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Br J Clin Pharmacol
मुख्य लेखकों: Bertani, Lorenzo, Baglietto, Laura, Antonioli, Luca, Fornai, Matteo, Tapete, Gherardo, Albano, Eleonora, Ceccarelli, Linda, Mumolo, Maria Gloria, Pellegrini, Carolina, Lucenteforte, Ersilia, de Bortoli, Nicola, Bellini, Massimo, Marchi, Santino, Blandizzi, Corrado, Costa, Francesco
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2020
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319004/
https://ncbi.nlm.nih.gov/pubmed/32027388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14235
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन